• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SEIKAGAKU CORPORATION ARTZ DISPO; ACID, HYALURONIC, INTRAARTICULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SEIKAGAKU CORPORATION ARTZ DISPO; ACID, HYALURONIC, INTRAARTICULAR Back to Search Results
Device Problem Insufficient Information (3190)
Patient Problem Unspecified Infection (1930)
Event Type  Injury  
Manufacturer Narrative
This case was reported from an injecting physician.The injecting physician considered that septic arthritis was possibly related to artz dispo.We are investigating the case from an treating physician.Company comment: all of product batches passed with the release test including the sterility test before the product release.It is therefore highly unlikely that the product quality was related to the septic arthritis.Manufacturer's causality assessment is determined as "not related".(b)(4).
 
Event Description
On (b)(6) 2020: a (b)(6) year-old male patient, who had received dozens of artz dispo injection as maintenance treatment for gonarthrosis, received an injection of artz dispo.On (b)(6) 2020: he had septic arthritis and was admitted to another hospital.It was in treatment.
 
Event Description
(b)(6) 2020: a (b)(6) male patient, who had received dozens of artz dispo injection as maintenance treatment for gonarthrosis, received an injection of artz dispo to right knee.(b)(6) unk: he had septic arthritis and was admitted to another hospital.It was in treatment.(b)(6) 2020: he was seen at the injection physician's clinic.His knee was improving.
 
Manufacturer Narrative
This is a definitive report.B5 and h10 were updated.The follow-up to the treating physician was not allowed by the injecting physician.The patient's condition was updated.The injecting physician considered that septic arthritis was possibly related to artz dispo.Company comment: all of product batches passed with the release test including the sterility test before the product release.It is therefore highly unlikely that the product quality was related to the septic arthritis.Manufacturer's causality assessment is determined as "not related".We selected the code of 4316 (appropriate term/code not available) for h.6 manufacturer evaluation conclusion code because the reported adverse event was not listed in the package insert and concerned lot number was not available.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARTZ DISPO
Type of Device
ACID, HYALURONIC, INTRAARTICULAR
Manufacturer (Section D)
SEIKAGAKU CORPORATION
marunouchi center building
6-1, marunouchi 1-chome
chiyoda-ku, tokyo 100-0 005
JA  100-0005
MDR Report Key9752241
MDR Text Key190516168
Report Number9612392-2020-00002
Device Sequence Number1
Product Code MOZ
Combination Product (y/n)N
PMA/PMN Number
P980044
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup
Report Date 02/07/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/25/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Date Manufacturer Received06/12/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
Patient Age72 YR
-
-